Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
BACKGROUND
Conventional compartmental pharmacokinetic models wrongly assume instantaneous drug mixing in the central compartment, resulting in a flawed prediction of drug disposition for the first minutes, and the flaw affects pharmacodynamic modeling. This study examined the influence of the administration rate and other covariates on early phase kinetics and dynamics of propofol by using the enlarged structural pharmacokinetic model.


METHODS
Fifty patients were randomly assigned to one of five groups to receive 1.2 mg/kg propofol given with the rate of 10 to 160 mg . kg(-1). h(-1). Arterial blood samples were taken frequently, especially during the first minute. The authors compared four basic pharmacokinetic models by using presystemic compartments and the time shift of dosing, LAG time. They also examined a sigmoidal maximum possible drug effect pharmacodynamic model. Patient characteristics and dose rate were obtained to test the model structure.


RESULTS
Our final pharmacokinetic model includes two conventional compartments enlarged with a LAG time and six presystemic compartments and includes following covariates: dose rate for transit rate constant, age for LAG time, and weight for central distribution volume. However, the equilibration rate constant between central and effect compartments was not influenced by infusion rate.


CONCLUSIONS
This study found that a combined pharmacokinetic-dynamic model consisting of a two-compartmental model with a LAG time and presystemic compartments and a sigmoidal maximum possible drug effect model accurately described the early phase pharmacology of propofol during infusion rate between 10 and 160 mg . kg(-1). h(-1). The infusion rate has an influence on kinetics, but not dynamics. Age was a covariate for LAG time.
Masui
Kenichi
K
Department of Anesthesiology, National Defense Medical College, Tokorozawa, Japan. kenichi@masuinet.com
Kira
Marimo
M
Kazama
Tomiei
T
Hagihira
Satoshi
S
Mortier
Eric P
EP
Struys
Michel M R F
MM
D000328:Adult; D000368:Aged; D000465:Algorithms; D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000494:pharmacology; D001499:Bayes Theorem; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography / Q000187:drug effects; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000494:pharmacology; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D016343:Monitoring, Intraoperative; D015742:Propofol / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000494:pharmacology
D018686:Anesthetics, Intravenous; D006993:Hypnotics and Sedatives; D015742:Propofol